Prescribing trends of proton pump inhibitors, antipsychotics and benzodiazepines of medicare part d providers.

Toth, Jennifer M; Jadhav, Saumil; Holmes, Holly M; Sharma, Manvi

Toth, Jennifer M; Jadhav, Saumil; Holmes, Holly M; Sharma, Manvi.

Afiliación

Toth JM; Department of Pharmacy Administration, The University of Mississippi, University, MS, 38677, USA. jtoth@go.olemiss.edu.
Jadhav S; Department of Pharmacy Administration, The University of Mississippi, University, MS, 38677, USA.
Holmes HM; Division of Geriatric and Palliative Medicine, McGovern Medical School, The University of Texas Health Science Center, Houston, TX, USA.
Sharma M; Department of Pharmacy Administration, The University of Mississippi, University, MS, 38677, USA.

BMC Geriatr ; 22(1): 306, 2022 04 09.

Article en En | MEDLINE | ID: mdl-35395728

Asunto(s)

Antipsicóticos; Medicare Part D; Anciano; Antipsicóticos/uso terapéutico; Benzodiazepinas/uso terapéutico; Estudios Transversales; Humanos; Prescripción Inadecuada/prevención & control; Pautas de la Práctica en Medicina; Inhibidores de la Bomba de Protones/uso terapéutico; Estudios Retrospectivos; Estados Unidos/epidemiología

Palabras clave

Antipsychotic; Benzodiazepine; Costs; Deprescribing; Geriatric; Medication use; Proton pump inhibitor

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Antipsicóticos / Medicare Part D Tipo de estudio: Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Humans País/Región como asunto: America do norte Idioma: En Año: 2022 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google